Potential Targeted Therapeutic Strategies for Overcoming Resistance in BRAF Wild Type Melanoma
Melanoma manifests itself from the malignant transformation of melanocytes and represents the deadliest form of skin cancer, being responsible for the disproportionate majority of all skin cancer deaths. The 2002 discovery that 50% of all melanoma patients possess activating BRAF mutations ignited a...
Main Author: | Rebecca, Vito William |
---|---|
Format: | Others |
Published: |
Scholar Commons
2014
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/5112 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=6308&context=etd |
Similar Items
-
Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
by: Xian Yang Chan, et al.
Published: (2017-07-01) -
BRAF and beyond: Tailoring strategies for the individual melanoma patient
by: Anthony Jarkowski, et al.
Published: (2014-01-01) -
Therapeutic Potential of Black Pepper Compound for BRaf Resistant Melanoma
by: Neel M. Fofaria, et al.
Published: (2017-11-01) -
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
by: Ernesto Rossi, et al.
Published: (2019-04-01) -
Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
by: Raphael Reinhard, MD, et al.
Published: (2018-03-01)